Table of Contents

SECTION 1 CLINICAL SPECTRUM

• Clinical Spectrum of Cardiodiabetes
• Risk Factors for Cardiodiabetes
• Cardiodiabetes in Children
• New Genes for Type 2 Diabetes: Indian Scenario
• Stress and Cardiodiabetes
• Hypothyroidism and Cardiodiabetes
• Cardiodiabetes and Insulin Resistance in Obesity: Clinical Relevance
• Anemia and Cardiodiabetes: Management Strategies
• Endothelial Dysfunction in Atrial Fibrillation with Type 2 DM
• ACS, Cardiodiabetes, and Women
• Coronary Artery Disease in Diabetes: How Different is It from Nondiabetics?
• Cardiodiabetes and Heart Failure in the Elderly
• Prognosis of Heart Failure in Diabetes: Newer Perspectives
• Cardiodiabetes Management and STEMI: Prognostication
• Small Vessel CAD in Cardiodiabetes
• Cardiodiabetes and Deep Venous Thrombosis
• Pregnancy and Cardiodiabetes
• Cardiodiabetes and Autonomic Insufficiency
• Cardiodiabetes and Pulmonary Embolism: Is the Outcome Different?
• Cardiodiabetes and Cutaneous Manifestations
• Benidipine for Hypertension in Chronic Kidney Disease with Cardiodiabetes
• Cardiorenal Diabetes: Triple Jeopardy
• Contrast-induced Acute Kidney Injury
• Cardiodiabetes and Hypertension: Double Jeopardy
• Cardiodiabetes and Obstructive Sleep Apnea
• Cardiodiabetes and Mind-Heart Connection
• Aortic Aneurysm Surgery in Cardiodiabetes: Is the Outcome Different?
• Cardiodiabetes and Syncope
• Cardiodiabetes and Sexual Dysfunction
• Cardiodiabetes and Erectile Dysfunction
• Endothelial Cell Dysfunction in DM, HT and CAD, and Its Pathophysiology

SECTION 2 DIAGNOSIS

• Current Status of Diabetic Cardiomyopathy
• Insulin Therapy and Cardiodiabetes
• Echo-guided CRT in Cardiodiabetes
• Echocardiography in Diabetes
• Echo/Doppler Assessment of Increased Left-sided Filling Pressures and Diastolic Heart Failure in Patients with Normal Systolic Function in Cardiodiabetes
• 3D Echo and Cardiodiabetes
• Emergency Echocardiography in Cardiodiabetes
• Diabetic Cardiomyopathy: Studies on Global Longitudinal Strain in Asymptomatic Diabetic Subjects
• Strain and Strain Rate Imaging in Cardiodiabetes
• Dobutamine Stress Echo for Coronary Artery Disease Evaluation in Diabetics
• Noninvasive Cardiovascular Imaging for Risk Assessment in Asymptomatic Diabetic Patients
• Value of Ankle–Brachial Index in Cardiodiabetes
• Computed Tomography Evaluation of Abdominal Arterial Wall Calcification in Patients with Type 2 Diabetes Mellitus
• Cardiac MRI: A Promise, Hope or Hype in Cardiodiabetes
• CT for CVD Evaluation in Cardiodiabetes
• Recent Advances in Nuclear Cardiology and Cardiodiabetes
• Blood Pressure Variability in Cardiodiabetes
• Central Aortic Blood Pressure Evaluation for Hypertension in Cardiodiabetics
• Telemedicine in Diabetes Management
• HbA1c: Clinical Relevance in Cardiodiabetes
• Emerging Role of Cardiac Troponin in Cardiodiabetes

SECTION 3 MANAGEMENT STRATEGIES

• Role of Yoga in Cardiodiabetes
• Metabolic Effects of Antihypertensive Drugs
• Potential Role of Rosuvastatin in Cardiodiabetes
• Diabetic Hypertriglyceridemia: Management Strategies
• High-density Lipoprotein in Cardiodiabetes
• Glucose-lowering Strategies and Cardiovascular Outcomes
• Improving CV Outcomes in Diabetes with New Antidiabetic Medications: A New Era has Begun
• Positioning of Once Weekly GLP–1- based Therapies for Whom and When?
• DPP-IV Inhibitors beyond Glycemic Efficacy
• Insulin Therapy and Cardiodiabetes in Critical Care
• Lixisenatide: A Cardiodiabetes Perspective
• SGLT2-i Agents and Cardiovascular Diabetology
• SGLT2-i for the Reduction of Cardiovascular Events in High-risk Patients with Diabetes Mellitus
• Diabetes and Heart Failure: New Data on the Role of SGLT 2 Inhibitors— A Change of Concept?
• Bisoprolol: Is It Superior in Cardiodiabetes?
• Bisoprolol: A Choice of Beta Blocker in Hypertension and ACS in Cardiodiabetes
• Bisoprolol in Heart Failure in Cardiodiabetes
• Nebivolol for Hypertension in Cardiodiabetes
• ARB for Hypertension in Cardiodiabetes
• CKD and Hypertension: Is Benidipine Beneficial?
• Azilsartan: Promise and Power for Hypertension in Cardiodiabetes
• Benidipine for Hypertension in Cardiodiabetes
• Azilsartan: A Molecule of First Choice for Hypertension in Cardiodiabetes
• Superiority of Telmisartan: ARB, the First Choice in Cardiodiabetes
• ARNI in Heart Failure with Cardiodiabetes: The Way Forward
• Indapamide versus Hydrochlorothiazide versus Chlorthalidone in Cardiodiabetes
• Polypill for Cardiovascular Protection in Diabetes
• Clopidogrel in Patients of Diabetes with Acute Coronary Syndrome
• Acute Coronary Syndrome in Cardiodiabetes: Is It Different?
• Newer Drugs in Heart Failure and Changes in Our Clinical Approach
• Role of Oral Anticoagulants in Atrial Fibrillation with Cardiodiabetes
• Low-molecular-weight Heparin in Acute Coronary Syndrome in Cardiodiabetes
• Myocardial Bridging
• Benidipine for Hypertension in STEMI with Cardiodiabetes
• Thrombolytic Therapy of Choice in STEMI with Cardiodiabetes
• Tenecteplase and ST-elevation Myocardial Infarction with Cardiodiabetes
• Cardiodiabetes and Stroke
• Hemorrhagic Stroke and Cardiodiabetes
• Prognostication of STEMI in Cardiodiabetes
• Management of Hypertension in Diabetes: Special Consideration
• Benidipine: A New Calcium Channel Blocker for Management of Hypertension and Angina in Cardiodiabetes
• Azilsartan for Hypertension Management in Cardiodiabetes
• Need for Registry of Cardiodiabetes in India
• Nonpharmacological Management of Cardiodiabetes
• Maternal Diabetes Mellitus and Fetal Cardiac Malformations: Antenatal and Postnatal Management and Outcome
• Role of Enhanced External Counterpulsation: Future Perspectives

SECTION 4 NUTRACEUTICAL AND OBESITY CARE

• Role of Vitamin D as Cardioprotection Strategy: Hope or Hype?
• Omega-3 Fatty Acids and Cardiovascular Disease
• Role of Red Yeast Rice and Phytosterols in Dyslipidemia
• Meal Replacement Therapy for Obesity Care in Cardiodiabetes
• Ideal Edible Oil in Cardiodiabetes
• Cardiodiabetic Diet

SECTION 5 ARRHYTHMIA MANAGEMENT

• Cardiodiabetes and Heart Rate Variability
• Natural History of Atrial Fibrillation in Cardiodiabetes: Is it Different?
• Atrial Fibrillation: Management Strategies in Cardiodiabetics
• Ventricular Tachycardia in Heart Failure with Cardiodiabetes
• Sudden Cardiac Death in Patients with Diabetes Mellitus: Prevalence, Predictors and Preventive Strategies
• Prevention of Sudden Cardiac Death in Cardiodiabetes
• Pacing in Cardiodiabetes
• Radiofrequency Ablation in Atrial Fibrillation in Cardiodiabetes
• LA Appendage Closure for AF in Cardiodiabetes: Is the Outcome Different?
• AICD after Cardiac Arrest in Cardiodiabetes

SECTION 6 INTERVENTION

• Coronary Interventions in Cardiodiabetes Prognostication
• Primary PCI for STEMI in Cardiodiabetes: What is the Outcome?
• Optimizing Results of Percutaneous Coronary Intervention in Multivessel Disease with Diabetes
• STEMI Management in Diabetes Mellitus: Is it Different?
• CTO with STEMI in Cardiodiabetes: Is the Outcome Different?
• Coronary Intervention in Venous Grafts in Diabetes
• Cardiodiabetes and Peripheral Vascular Interventions
• Cardiodiabetes and Vasculopathy
• Cardiodiabetes and Carotid Artery Interventions
• Coronary Revascularization in Diabetics
• Endovascular Intervention in Stroke in Cardiodiabetes: New Frontiers

SECTION 7 CARDIAC SURGERY

• Coronary Artery Bypass Grafting in Cardiodiabetes
• Cardiac Surgery and Diabetes
• ECMO for Cardiodiabetes

SECTION 8 REHABILITATION

• Cardiac Rehabilitation in Cardiodiabetes
• Post-STEMI Intervention: Rehabilitation in Cardiodiabetes
• Role of Nurses in a Structured Manner for Cardiac Rehabilitation in Cardiodiabetes

SECTION 9 FUTURE DIRECTIONS

• Type 2 Diabetes and Coronary Artery Bypass Grafting: Relation and Outcomes

About the Author

HK Chopra
Senior Consultant Cardiologist, Moolchand Medicity, New Delhi, India